Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Le Feuvre

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
European Journal of Heart Failure|April 11, 2017
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trialJean-Sébastien Hulot, Joe-Elie Salem, Alban Redheuil, et al.
European Heart Journal|September 14, 2015
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trialGérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
European Journal of Heart Failure|April 11, 2017
Effect of intracoronary administration of AAV1/SERCA2a on ventricular remodelling in patients with advanced systolic heart failure: results from the AGENT-HF randomized phase 2 trialJean-Sébastien Hulot, Joe-Elie Salem, Alban Redheuil, et al.
European Heart Journal|September 14, 2015
Stopping or continuing clopidogrel 12 months after drug-eluting stent placement: the OPTIDUAL randomized trialGérard Helft, Philippe Gabriel Steg, Claude Le Feuvre, et al.
Pageof 5